1. 2327 Comparison between Child Pugh A5 vs A6 and ALBI grade 1 vs 2 in patients treated with sorafenib for HCC. (September 2015) Authors: Edeline, J.; Blanc, J.F.; Johnson, P.; Ross, P.; Ma, Y.T.; King, J.; Hubner, R.; Graham, J.; Darby, S.; Evans, J.; Iwuji, C.; Swinson, D.; Collins, P.; Patel, K.; Muazzam, I.; Palmer, D.; Meyer, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2338 Efficacy and safety of sorafenib as first-line therapy of patients (pts) with advanced Child-Pugh B Hepatocellular Carcinoma (HCC): A systematic review and meta-analysis. (September 2015) Authors: McNamara, M.; Slagter, A.; Rigby, C.; Lamarca, A.; Valle, J.; Hubner, R.; Amir, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗